Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-19 Sale | 2024-12-20 4:20 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 1,291 | $8 | $10,328 | 100,067 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:51 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 4,325 | $11.72 | $50,689 | 101,358 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 4:30 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 3,435 | $11.1 | $38,129 | 97,174 (Indirect Direct) | View |
| 2024-01-19 Sale | 2024-01-22 8:22 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 6,307 | $7.7533 | $48,900 | 220,609 (Indirect Direct) | View |
| 2023-11-20 Sale | 2023-11-21 4:40 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 2,127 | $7.2415 | $15,403 | 104,195 (Indirect Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:55 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 12,492 | $8.8753 | $110,871 | 106,322 (Indirect Direct) | View |
| 2023-06-02 Sale | 2023-06-05 6:32 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 1,960 | $11.41 | $22,368 | 68,845 (Indirect Direct) | View |
| 2023-05-22 Sale | 2023-05-23 12:15 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 2,110 | $12.87 | $27,165 | 70,805 (Indirect Direct) | View |
| 2023-04-06 Sale | 2023-04-07 3:18 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 3,439 | $7.27 | $25,002 | 72,915 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:03 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 2,032 | $8.5309 | $17,335 | 76,354 (Indirect Direct) | View |
| 2022-11-21 Sale | 2022-11-23 4:10 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 2,159 | $9.6 | $20,726 | 43,680 (Indirect Direct) | View |
| 2022-05-13 Purchase | 2022-05-16 8:43 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 6,000 | $0 | $0 | 26,000 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:34 pm | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 331 | $7.58 | $2,509 | 44,082 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 1:15 pm | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 2,587 | $12.03 | $31,122 | 14,913 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-18 11:36 am | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 2,500 | $15.85 | $39,625 | 2,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-31 Option Award | 2024-05-31 6:37 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 7,500 | $0 | 104,674 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 8:22 pm | N/A 2034-01-17 | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 120,000 | $0 | 220,609 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 4:55 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 22,500 | $0 | 106,322 (Direct) | View |
| 2023-07-14 Option Award(A) | 2023-07-21 8:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 25,000 | $0 | 95,180 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:00 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 25,000 | $1 | 96,314 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-20 7:32 pm | N/A 2033-01-18 | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 88,000 | $0 | 133,386 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 7,500 | $0 | 45,839 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:17 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 12,000 | $0 | 38,000 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-06 8:50 pm | N/A 2032-04-04 | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 37,500 | $0 | 44,082 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 666 | $0 | 44,082 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 1:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 5,000 | $0 | 14,913 (Direct) | View |
| 2021-06-05 Option Award | 2021-06-08 2:33 pm | N/A 2031-05-31 | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:57 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 8,000 | $0 | 8,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:37 pm | N/A 2030-09-30 | UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | Henderson Molly Executive Vice President & CFO | 50,000 | $0 | 50,000 (Direct) | View |